Literature DB >> 21792521

Spinal anaesthesia and monitored conscious sedation for repair of infantile meningomyelocele.

Olufemi E Idowu1, Stephen O Oyeleke.   

Abstract

OBJECTIVES: Monitored conscious sedation combined with spinal anaesthesia (MCSS) to repair myelomeningocoele (MM) has received little attention in the literature. It has the potential of rapid postoperative recovery, minimal perioperative morbidity and probable reduced cost of management. The objective of this study was to prospectively analyze the safety and effectiveness of MCSS during repair of MM in infants.
MATERIALS AND METHODS: This series consists of a prospective study of the clinical features, anaesthetic technique and perioperative outcome of 30 infants who underwent repair of MM under MCSS. The procedure was considered safe and effective if no event occurred during anaesthesia resulting in the procedure being aborted or postoperative complication related to the anaesthetic technique.
RESULTS: There were 19 males and 11 females. The median age of the patients was 3 months ranging from 2 days to 12 months. The study included patients with lumbar (four patients), lumbosacral (23 patients) and sacral (three patients) MM. None of the cases needed to be converted to general anaesthesia. The mean duration of surgery was 56.4 min (median = 55 min; range of 40-85 min). There was no significant perioperative morbidity or mortality.
CONCLUSIONS: The prevailing adverse socioeconomic status, health undermining religious belief, paucity of neurosurgeons/neuroanaesthetists and inadequate facilities in sub-Saharan Africa delay the presentation and surgical intervention of patients with MM. This technique is useful if the exclusion criteria are adhered to and should be considered as one of the armamentarium in economically challenged environments as it is probably cheaper than general anaesthesia.

Entities:  

Mesh:

Year:  2011        PMID: 21792521     DOI: 10.1007/s00381-011-1494-x

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  18 in total

1.  The semantics of ketamine.

Authors:  S M Green; B Krauss
Journal:  Ann Emerg Med       Date:  2000-11       Impact factor: 5.721

Review 2.  Monitored anesthesia care and loco-regional anesthesia. Vascular surgery use.

Authors:  G Savoia; M Loreto; E Gravino; G Canfora; A Frangiosa; P Cortesano; F Russo
Journal:  Minerva Anestesiol       Date:  2005-09       Impact factor: 3.051

3.  Conscious sedation v. monitored anaesthesia care--20 years in the South African context.

Authors:  Tish Stefanutto; Tom Ruttmann
Journal:  S Afr Med J       Date:  2006-12

4.  Ketamine-induced intracranial hypertension.

Authors:  S R Wyte; H M Shapiro; P Turner; A B Harris
Journal:  Anesthesiology       Date:  1972-02       Impact factor: 7.892

5.  Modification of ketamine-induced intracranial hypertension in neurosurgical patients by pretreatment with midazolam.

Authors:  M Belopavlovic; A Buchthal
Journal:  Acta Anaesthesiol Scand       Date:  1982-10       Impact factor: 2.105

6.  Hydrocephalus in myelomeningocele.

Authors:  S C Stein; L Schut
Journal:  Childs Brain       Date:  1979

7.  Improved outcome utilizing spinal anesthesia in high-risk infants.

Authors:  K H Sartorelli; J C Abajian; J M Kreutz; D W Vane
Journal:  J Pediatr Surg       Date:  1992-08       Impact factor: 2.545

8.  Irreversible conduction block in isolated nerve by high concentrations of local anesthetics.

Authors:  L A Lambert; D H Lambert; G R Strichartz
Journal:  Anesthesiology       Date:  1994-05       Impact factor: 7.892

9.  Outcome of myelomeningocoele repair in sub-Saharan Africa: the Nigerian experience.

Authors:  O E Idowu; R A Apemiye
Journal:  Acta Neurochir (Wien)       Date:  2008-08-23       Impact factor: 2.216

Review 10.  Transient neurologic symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics.

Authors:  D Zaric; C Christiansen; N L Pace; Y Punjasawadwong
Journal:  Cochrane Database Syst Rev       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.